OOIR: Observatory of International Research

Papers

(The median citation count of Drug Testing and Analysis is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Performance evaluation of handheld Raman spectroscopy for cocaine detection in forensic case samples	47
Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 Consensus of Basel)	45
Implementing an integrated multi‐technology platform for drug checking: Social, scientific, and technological considerations	40
The metabolism of the synthetic cannabinoids ADB‐BUTINACA and ADB‐4en‐PINACA and their detection in forensic toxicology casework and infused papers seized in prisons	38
Sports drug testing and the athletes' exposome	36
Metonitazene in the United States—Forensic toxicology assessment of a potent new synthetic opioid using liquid chromatography mass spectrometry	36
A review of nicotine‐containing electronic cigarettes—Trends in use, effects, contents, labelling accuracy and detection methods	34
A transnational perspective on the evolution of the synthetic cannabinoid receptor agonists market: Comparing prison and general populations	32
Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis	32
Identification of AD‐18, 5F‐MDA‐19, and pentyl MDA‐19 in seized materials after the class‐wide ban of synthetic cannabinoids in China	31
No pain, just gain: Painless, easy, and fast dried blood spot collection from fingertip and upper arm in doping control	31
Shape matters: The application of activity‐based in vitro bioassays and chiral profiling to the pharmacological evaluation of synthetic cannabinoid receptor agonists in drug‐infused papers seiz	30
Electrochemical profiling and liquid chromatography–mass spectrometry characterization of synthetic cathinones: From methodology to detection in forensic samples	30
Hexahydrocannabinol and closely related semi‐synthetic cannabinoids: A comprehensive review	29
Longitudinal evaluation of multiple biomarkers for the detection of testosterone gel administration in women with normal menstrual cycle	29
Simultaneous testing for anabolic steroids in human hair specimens collected from various anatomic locations has several advantages when compared with the standard head hair analysis	27
Stability of synthetic cathinones in clinical and forensic toxicological analysis—Where are we now?	27
Pharmacokinetics and effects on arachidonic acid metabolism of low doses of cannabidiol following oral administration to horses	26
From JWH‐018 to OXIZIDS: Structural evolution of synthetic cannabinoids in the European Union from 2008 to present day	26
Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists	26
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of bindin	26
Annual banned‐substance review: Analytical approaches in human sports drug testing 2019/2020	25
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of bindin	24
A calibration friendly approach to identify drugs of abuse mixtures with a portable near‐infrared analyzer	24
Annual banned‐substance review: Analytical approaches in human sports drug testing 2020/2021	23

Urinary steroid profile in relation to the menstrual cycle	23
What's in fake ‘Xanax’?: A dosage survey of designer benzodiazepines in counterfeit pharmaceutical tablets	22
Development and validation of a rapid LC‐MS/MS method for the detection of 182 novel psychoactive substances in whole blood	22
Large‐scale evaluation of ion mobility spectrometry for the rapid detection of synthetic cannabinoid receptor agonists in infused papers in prisons	21
NPS detection in prison: A systematic literature review of use, drug form, and analytical approaches	21
Determination of the enantiomeric composition of amphetamine, methamphetamine and 3,4‐methylendioxy‐N‐methylamphetamine (MDMA) in seized street drug samples from southern Germany	20
Do dried blood spots have the potential to support result management processes in routine sports drug testing?—Part 2: Proactive sampling for follow‐up investigations concerning atypical or adverse an	20
Preliminary data on the potential for unintentional antidoping rule violations by permitted cannabidiol (CBD) use	20
Adulteration of low‐delta‐9‐tetrahydrocannabinol products with synthetic cannabinoids: Results from drug checking services	19
Stability and detectability of testosterone esters in dried blood spots after intramuscular injections	19
Analytical characterization of “etonitazepyne,” a new pyrrolidinyl‐containing 2‐benzylbenzimidazole opioid sold online	19
Fully automated dried blood spot sample handling and extraction for serological testing of SARS‐CoV‐2 antibodies	19
The Society of Hair Testing consensus on general recommendations for hair testing and drugs of abuse testing in hair	18
Metabolite elucidation of 2‐fluoro‐deschloroketamine (2F‐DCK) using molecular networking across three complementary in vitro and in vivo models	18
Analytical and medico‐legal problems linked to the presence of delta‐8‐tetrahydrocannabinol (delta‐8‐THC): Results from urine drug testing in Sweden	18
Organ‐on‐a‐chip: Determine feasibility of a human liver microphysiological model to assess long‐term steroid metabolites in sports drug testing	18
On‐site forensic analysis of colored seized materials: Detection of brown heroin and MDMA‐tablets by a portable NIR spectrometer	17
Metabolic profiling of deschloro‐N‐ethyl‐ketamine and identification of new target metabolites in urine and hair using human liver microsomes and high‐resolution accurate mass spectrometry	17
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of bindin	17
Metabolomics in clinical and forensic toxicology, sports anti‐doping and veterinary residues	17
New synthetic cannabinoids carrying a cyclobutyl methyl side chain: Human Phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl‐CBMICA and Cumyl‐CBMINACA	17
Metabolic studies of hypoxia‐inducible factor stabilisers IOX2, IOX3 and IOX4 (in vitro) for doping control	17
A validated method for the simultaneous quantification of cannabidiol, Δ⁹‐tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabid	16
Hair analysis can support the follow‐up addiction care after acute New Psychoactive Substances intoxication: Illustration by two cases	16
Detection of the selective androgen receptor modulator GSK2881078 and metabolites in urine and hair after single oral administration	16
A new cannabinoid receptor 1 selective agonist evading the 2021 “China ban”: ADB‐FUBIATA	16
Analysis of cobalt for human sports drug testing purposes using ICP‐ and LC‐ICP‐MS	16
Comparative assessment of electronic nicotine delivery systems aerosol and cigarette smoke on endothelial cell migration: The Replica Project	16
EPO transgene detection in dried blood spots for antidoping application	16
Optimizing detection of erythropoietin receptor agonists from dried blood spots for anti‐doping application	16
β₂‐Adrenoceptor agonist activity of higenamine	15
Automated online dried blood spot sample preparation and detection of anabolic steroid esters for sports drug testing	15
Increase in drugs‐of‐abuse findings in post‐mortem toxicology due to COVID‐19 restrictions—First observations in Finland	15
A fast screening method for the detection of CERA in dried blood spots	15
Development and validation of a fast ultra‐high‐performance liquid chromatography tandem mass spectrometry method for determining carbonic anhydrase inhibitors and their metabolites in urine and hair	15
An infrared spectroscopic approach to characterise white powders, easily applicable in the context of drug checking, drug prevention and on‐site analysis	15
Detection of clenbuterol residues in beef sausages and its enantiomeric analysis using UHPLC–MS/MS: A risk of unintentional doping in sport field	15
Identification of the synthetic cannabinoid‐type new psychoactive substance, CH‐PIACA, in seized material	14
Single hair analysis: Validation of a screening method for over 150 analytes and application on documented single‐dose cases	14
Presence of the ketamine analog of 2‐fluorodeschloroketamine residues in wastewater	14
Determination of amphetamine enantiomers in urine by conductive vial electromembrane extraction and ultra‐high performance supercritical fluid chromatography tandem mass spectrometry	14
Detection of AP‐237 and synthetic cannabinoids on an infused letter sent to a German prisoner	14
The use of RNA‐based 5'‐aminolevulinate synthase 2 biomarkers in dried blood spots to detect recombinant human erythropoietin microdoses	13
Monitoring methamphetamine in the United States: A two‐decade review as seen by the DEA methamphetamine profiling program	13
A quantitative PCR screening method for adeno‐associated viral vector 2‐mediated gene doping	13
Immature reticulocytes are sensitive and specific to low‐dose erythropoietin treatment at sea level and altitude	13
Optimization and implementation of four duplex quantitative polymerase chain reaction assays for gene doping control in horseracing	13
New qualitative analysis strategy for illicit drugs using Raman spectroscopy and characteristic peaks method	13
Identification of Hypoxia‐inducible factor (HIF) stabilizer roxadustat and its possible metabolites in thoroughbred horses for doping control	13
Liquid chromatography–mass spectrometry behavior of Girard's reagent T derivatives of oxosteroid intact phase II metabolites for doping control purposes	12

Dried blood spots for anti‐doping: Why just going volumetric may not be sufficient	12
Annual banned‐substance review—Analytical approaches in human sports drug testing 2021/2022–	12
Pharmacokinetics of freebase nicotine and nicotine salts following subcutaneous administration in male rats	12
PEth 16:0/18:1 and 16:0/18:2 after consumption of low doses of alcohol—A contribution to cutoff discussion	12
Emergence of the less common cannabinoid Δ⁸‐Tetrahydrocannabinol in a doping sample	12
A review of cannabidiol‐containing electronic liquids—Current regulations and labelling accuracy	12
Discovery of c.577del in EPO: Investigations into endogenous EPO double‐band detected in blood with SAR‐PAGE	12
EMCDDA framework and practical guidance for naming synthetic cannabinoids	12
Data from a microdosed recombinant human erythropoietin administration study applying the new biotinylated clone AE7A5 antibody and a further optimized sarcosyl polyacrylamide gel electrophoresis prot	11
The application of laboratory‐based analytical tools and techniques for the quality assessment and improvement of commercial antivenoms used in the treatment of snakebite envenomation	11
Advances in the detection of growth hormone releasing hormone synthetic analogs	11
Prevalence and concentrations of new designer stimulants, synthetic opioids, benzodiazepines, and hallucinogens in postmortem hair samples: A 13‐year retrospective study	11
The colloidal gold nanoparticle‐based lateral flow immunoassay for fast and simple detection of plant‐derived doping agent, higenamine	11
Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1‐valeroyl‐d‐lysergic acid diethylamide (1V‐LSD)	11
Stability of phosphatidylethanol 16:0/18:1 in authentic and spiked whole blood	11
In vitro studies of hypoxia inducible factor‐prolyl hydroxylase inhibitors daprodustat, desidustat, and vadadustat for equine doping control	11
From a non‐targeted metabolomics approach to a targeted biomarkers strategy to highlight testosterone abuse in equine. Illustration of a methodological transfer between platforms and laboratories	11
Identification of equine in vitro metabolites of seven non‐steroidal selective androgen receptor modulators for doping control purposes	11
Long‐term monitoring of IOX4 in horse hair and its longitudinal distribution with segmental analysis using liquid chromatography/electrospray ionization Q Exactive high‐resolution mass spectrometry fo	11
Quantitative determination of five cannabinoids in blood and urine by gas chromatography tandem mass spectrometry applying automated on‐line solid phase extraction	11
Evaluation of blood parameters by linear discriminant models for the detection of testosterone administration	11
The ADEBAR project: European and international provision of analytical data from structure elucidation and analytical characterization of NPS	10
Removal of the influence of plasma volume fluctuations for the athlete biological passport and stability of haematological variables in active women taking oral contraception	10
Non‐contact detection of fentanyl by a field‐portable ion mobility spectrometer	10
Hair testing for acetazolamide as an evidence of the use of a contaminated dietary supplement	10
E‐cigarette puffing topography: The importance of assessing user behaviour to inform emissions testing	10
Stanozolol‐N‐glucuronide metabolites in human urine samples as suitable targets in terms of routine anti‐doping analysis	10
Elimination profiles of prednisone and prednisolone after different administration routes: Evaluation of the reporting level and washout periods to ensure safe therapeutic administrations	10
Low‐copy transgene detection using nested digital polymerase chain reaction for gene‐doping control	10
Robustness of digital PCR and real‐time PCR against inhibitors in transgene detection for gene doping control in equestrian sports	10
In vitro cytoxicity profile of e‐cigarette liquid samples on primary human bronchial epithelial cells	10
Sensitive screening of synthetic cannabinoids using liquid chromatography quadrupole time‐of‐flight mass spectrometry after solid phase extraction	10
Metabolism of 4F‐MDMB‐BICA in zebrafish by liquid chromatography–high resolution mass spectrometry	10
Development of an electrochemical flow‐through cell for the fast and easy generation of isotopically labeled metabolite standards	10
Estimation of alcohol and nicotine consumption in 11 cities of Turkey using wastewater‐based epidemiology	10
Further development of a liquid chromatography–high‐resolution mass spectrometry/mass spectrometry‐based strategy for analyzing eight biomarkers in human urine indicating toxic mushroom or Ric	10
Carbon and nitrogen isotopic analysis of morphine from opium and heroin samples originating in the four major heroin producing regions	9
Risk of unintentional antidoping rule violations by consumption of hemp products	9
A cell‐free bioassay for the detection of androgens	9
No association between psychiatric symptoms and doses of anabolic steroids in a cohort of male and female bodybuilders	9
Analytical developments of p‐hydroxy prenylamine reference material for dope control research: Characterization and purity assessment	9
Feasibility of microvolumetric capillary whole blood collections for usage in Athlete Biological Passport analysis	9
Direct sequence confirmation of qPCR products for gene doping assay validation in horses	9
Analysis of highly potent synthetic opioid nitazene analogs and their positional isomers	9
Meldonium residues in milk: A possible scenario for inadvertent doping in sports?	9
DNA damage in human oral cells induced by use of e‐cigarettes	9
Two‐dimensional high performance liquid chromatography purification of underivatized urinary testosterone and metabolites for compound‐specific stable carbon isotope analysis	9
Detection of intact insulin analogues in post‐mortem vitreous humour—Application to forensic toxicology casework	9
Development of an improved method to estimate the days of continuous drug ingestion, based on the micro‐segmental hair analysis	9
Improved separation of fentanyl isomers using metal cation adducts and high‐resolution ion mobility‐mass spectrometry	9
Detection of clostebol in sports: Accidental doping?	9
Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P‐AL‐LAD	9
Orally administered cannabidiol does not produce false‐positive tests for Δ⁹‐tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000	9
New application of the CRISPR‐Cas9 system for site‐specific exogenous gene doping analysis	9
Separating the wheat from the chaff: Observations on the analysis of lysergamides LSD, MIPLA, and LAMPA	8
Detection of insulin analogues and large peptides >2 kDa in urine	8
Label‐free proteomics for discovering biomarker candidates of RAD140 administration to castrated horses	8
HepG2 as promising cell‐based model for biosynthesis of long‐term metabolites: Exemplified for metandienone	8
Detection of undeclared doping substances in nutritional supplements in the context of follow‐up investigations concerning adverse analytical findings	8
Illicit drug profiling: A historical perspective	8
Detection of γ‐hydroxybutyric acid‐related acids in blood plasma and urine: Extending the detection window of an exogenous γ‐hydroxybutyric acid intake?	8
Comparison of urinary mercapturic acid excretions in users of various tobacco/nicotine products	8
Hair testing applied to the assessment of in utero exposure to drugs: Critical analysis of 51 cases of the University Hospital of Verona	8
Red blood cell derived extracellular vesicles during the process of autologous blood doping	8
Air monitoring for synthetic cannabinoids in a UK prison: Application of personal air sampling and fixed sequential sampling with thermal desorption two‐dimensional gas chromatography coupled to time‐	8
The effect of creatine ingestion on urinary creatinine concentration: Does supplementation mask a heavy dilution?	8
Re‐evaluation of combined ((ES/EG)/(TS/TG)) ratio as a marker of testosterone intake in men	8
Intelligence‐based doping control planning improves testing effectiveness: Perspectives from a national anti‐doping organisation	8
Detection of pharmaceuticals in “dirty sprite” using gas chromatography and mass spectrometry	8
Doping detection in animals: A review of analytical methodologies published from 1990 to 2019	8
Cannabinoid‐based vaping products and supplement formulations reported by consumers to precipitate adverse effects	8
Measurements of hydrocortisone and cortisone for longitudinal profiling of equine plasma by liquid chromatography–tandem mass spectrometry	8
Analytical strategy for the detection of ecdysterone and its metabolites in vivo in uPA(+/+)‐SCID mice with humanized liver, human urine samples, and estimation of prevalence of its use in anti‐doping	8
Transthyretin as a target of alkylation and a potential biomarker for sulfur mustard poisoning: Electrophoretic and mass spectrometric identification and characterization	8
An in vitro assay approach to investigate the potential impact of different doping agents on the steroid profile	8
miRNAs detection in equine plasma by quantitative polymerase chain reaction for doping control: Assessment of blood sampling and study of eca‐miR‐144 as potential erythropoiesis stimulating agent biom	8
Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow‐up study	8
Unauthorized ingredients in “nootropic” dietary supplements: A review of the history, pharmacology, prevalence, international regulations, and potential as doping agents	8
Driving license regranting: Hair EtG, serum CDT, and the role of sociodemographic and medicolegal variables	8
Human phase‐I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F‐EDMB‐PICA and EDMB‐PINACA	8

Comprehensive metabolic study of IOX4 in equine urine and plasma using liquid chromatography/electrospray ionization Q Exactive high‐resolution mass spectrometer for the purpose of doping control	8
In vitro metabolic studies of novel selective androgen receptor modulators and their use for doping control analysis	7
Procollagen type III amino‐terminal propeptide and insulin‐like growth factor I as biomarkers of growth hormone administration	7
Investigation of in vitro generated metabolites of GLPG0492 using equine liver microsomes for doping control	7
Tenofovir and emtricitabine concentrations in hair are comparable between individuals on tenofovir disoproxil fumarate versus tenofovir alafenamide‐based ART	7
Identification of potential biomarkers in urine and plasma after consumption of tobacco product in horses	7
Excretion of 19‐norandrosterone after consumption of boar meat	7
Differentiation of boldenone administration from ex vivo transformation in the urine of castrated male horses	7
The effects of iron injection on blood doping biomarkers in dried blood spots	7
Hair analysis for beta‐blockers and calcium‐channel blockers by using liquid chromatography‐tandem mass spectrometry as a tool for monitoring adherence to antihypertensive therapy	7
Doping in the Ultimate Fighting Championship (UFC): A 4‐year epidemiological analysis	7
Post‐mortem investigation into a death involving doping agents: The case of a body builder	7
Development and validation of an analytical method for the simultaneous determination of the alcohol biomarkers ethyl glucuronide, ethyl sulfate, N‐acetyltaurine, and 16:0/18:1‐phosphatidylethanol in	7
The presence of doping agents in dietary supplements: A glimpse into the Brazilian situation	7
Determination of drugs in exhumed liver and brain tissue after over 9 years of burial by liquid chromatography–tandem mass spectrometry—Part 2: Benzodiazepines, opioids, and further drugs	7
Detection of testosterone microdosing in healthy females	7
Detection of LongR³‐IGF‐I, Des(1‐3)‐IGF‐I, and R³‐IGF‐I using immunopurification and high resolution mass spectrometry for antidoping purposes	7
The duration of ketamine detection in hair after treatment cessation: Case study and review of the literature in forensic and clinical casework	7
Development of a point‐of‐care test for the detection of MDMA in latent fingerprints using surface plasmon resonance and lateral flow technology	7
Metabolism of third generation synthetic cannabinoids using zebrafish larvae	7
Doping control analysis of trimetazidine in dried blood spot	7
Application of single hair analysis in a doping case involving amphetamine	7
Use of mitochondrial sequencing to detect gene doping in horses via gene editing and somatic cell nuclear transfer	7
A comprehensive UHPLC–MS/MS method for the analysis of endogenous and exogenous steroids in serum for anti‐doping purposes	7
Quantification of hordenine in a complex plant matrix by direct analysis in real time–high‐resolution mass spectrometry: Application to the “plant of concern” Sceletium tortuosum	7
Quantification of (9R)‐ and (9S)‐hexahydrocannabinol (HHC) via GC–MS in serum/plasma samples from drivers suspected of cannabis consumption and immunological detection of HHC and related	7
Use of liquid chromatography‐tandem mass spectrometry for determination of higenamine in urine following oral administration of traditional Chinese medicine	7
Sexually transmitted doping: The impact of urine contamination of semen	7
Trace residue identification, characterization, and longitudinal monitoring of the novel synthetic opioid β‐U10, from discarded drug paraphernalia	7
On the road of dried blood spot sampling for antidoping tests: Detection of GHRP‐2 abuse	7
Changing trends in novel benzodiazepine use within Scottish prisons: detection, quantitation, prevalence, and modes of use	7
Air monitoring for illegal drugs including new psychoactive substances: A review of trends, techniques and thermal degradation products	7
Genetic individual identification from dried urine spots: A complementary tool to drug monitoring and anti‐doping testing	7
Nontargeted detection of designer androgens: Underestimated role of in vitro bioassays	7
Operation of the anti‐doping laboratory for the Beijing 2022 Olympic and Paralympic Winter Games	7
Characterization of new psychoactive substances by integrating benchtop NMR to multi‐technique databases	6
Disposition of serum steroids in response to combined oral contraceptives and menstrual cycle phases: A double‐blind, randomized, placebo‐controlled study	6
Kinetic profile of N,N‐dimethyltryptamine and β‐carbolines in saliva and serum after oral administration of ayahuasca in a religious context	6
Biomarker ratios	6
Rapid screening of 2‐benzylbenzimidazole nitazene analogs in suspect counterfeit tablets using Raman, SERS, DART‐TD‐MS, and FT‐IR	6
Fast and highly sensitive determination of tetrahydrocannabinol (THC) metabolites in hair using liquid chromatography‐multistage mass spectrometry (LC–MS³)	6
Carfentanil structural analogs found in street drugs by paper spray mass spectrometry and their characterization by high‐resolution mass spectrometry	6
Establishment of a post‐race biomarkers database and application of pathway analysis to identify potential biomarkers in post‐race equine plasma	6
Investigations into the stable isotope ratios of 1‐phenyl‐2‐propanone	6
Investigations into Annona fruit consumption as a potential source of dietary higenamine intake in the context of sports drug testing	6
Identification and analytical characterization of N‐propyl norbutylone, N‐butyl norbutylone, N‐benzyl norheptedrone, and N‐pyrrolidinyl‐3,4‐DMA	6
Discrepancies between validated GC‐FID and UHPLC‐DAD methods for the analysis of Δ‐9‐THC and CBD in dried hemp flowers	6
Human abuse liability assessment of e‐cigarettes: Why, what and how?	6
Indirect biomarkers of blood doping: A systematic review	6
Interpretation of hair and nails findings in an infant death case related to maternal addiction to tramadol	6
Nitrosamine formation from the reaction of methamphetamine with gaseous nitrous acid	6
Per‐ and polyfluoroalkyl substances (PFAS) determination in shellfish by liquid chromatography coupled to accurate mass spectrometry	6
Chemical analysis of selected harmful and potentially harmful constituents and in vitro toxicological evaluation of leading flavoured e‐cigarette aerosols in the Chinese market	6
Assessment of biological matrices for the detection of in utero cannabis exposure	6
Structure elucidation of the novel synthetic cannabinoid Cumyl‐Tosyl‐Indazole‐3‐Carboxamide (Cumyl‐TsINACA) found in illicit products in Germany	6
Real‐time electrochemical screening of cocaine in lab and field settings with automatic result generation	6
Key challenges for in vitro testing of tobacco products for regulatory applications: Recommendations for dosimetry	6
Metabolic study of hypoxia‐inducible factor stabilizers BAY 87‐2243, MK‐8617, and PT‐2385 in equine liver microsomes for doping control	6
The intra‐individual stability of GH biomarkers IGF‐I and P‐III‐NP in relation to GHRH administration, menstrual cycle, and hematological parameters	6
Synthetic origin of illicit methylamphetamine in Australia: 2011–2020	6
Intelligence benefit of the 3‐methoxytyramine to tyramine ratio in equine urine	6
Investigations in carbon isotope ratios of seized testosterone and boldenone preparations	6
Pitfalls in assessing the exogenous origin of GHB in hair	6
Abuse of nutmeg seeds: Detectable by means of liquid chromatography‐mass spectrometry techniques?	6
Pharmacokinetics of salmeterol and its main metabolite α‐hydroxysalmeterol after acute and chronic dry powder inhalation in exercising endurance‐trained men: Implications for doping control	6
An optimized SDS‐PAGE protocol with a new blotting system for the initial testing procedure of ESAs in doping control	6
Quantification of thyroid hormones and analogs by liquid chromatography coupled to mass spectrometry. Preliminary results in athletes and non‐athletes serum samples	6
Long‐term stability study and evaluation of intact steroid conjugate ratios after the administration of endogenous steroids	6
Determination of the Time since Deposition of blood‐traces in a forensic context: Application of untargeted LC‐HR‐MS/MS metabolomics profiling	6
In vitro and in vivo metabolism of the anabolic‐androgenic steroid oxandrolone in the horse	6
A multiplex qPCR assay for transgenes detection: A novel approach for gene doping control in horseracing using conventional laboratory setup	6
Detection of amfepramone and its metabolite cathinone in human hair: Application to a uthentic cases of amfepramone use	5
Fatty acid esters as novel metabolites of γ‐hydroxybutyric acid: A preliminary investigation	5
Doping control analyses during the Tokyo 2020 Olympic and Paralympic Games	5
Urine concentrations of vilanterol and its metabolites, GSK932009 and GW630200, after inhalation of therapeutic and supratherapeutic doses	5
Toxic plants—Detection of colchicine in a fast systematic clinical toxicology screening using liquid chromatography–mass spectrometry	5
Presence of higenamine in beetroot containing ‘foodstuffs’ and the implication for WADA‐relevant anti‐doping testing	5
Evaluation of longitudinal ¹³C isotope ratio mass spectrometric data in antidoping analysis	5
Microsampling: A role to play in Covid‐19 diagnosis, surveillance, treatment and clinical trials	5
Supra‐physiological doses of anabolic androgenic steroids impact erythropoietin and blood parameters	5
Investigation of the μ‐ and κ‐opioid receptor activation by eight new synthetic opioids using the [³⁵S]‐GTPγS assay: U‐47700, isopropyl U‐47700, U‐49900, U‐47931E, N‐methyl U‐47931E,	5
Effects of the administration of miconazole by different routes on the biomarkers of the “steroidal module” of the Athlete Biological Passport	5
Quantification of cannabinoids in human hair using a modified derivatization procedure and liquid chromatography–tandem mass spectrometry	5
Towards compound identification of synthetic opioids in nontargeted screening using machine learning techniques	5
Determination of buprenorphine, norbuprenorphine, naloxone, and their glucuronides in urine by liquid chromatography–tandem mass spectrometry	5
Detection and confirmation of zilpaterol in equine hair using liquid chromatography–mass spectrometry	5
Detecting the abuse of 19‐norsteroids in doping controls: A new gas chromatography coupled to isotope ratio mass spectrometry method for the analysis of 19‐norandrosterone and 19‐noretiocholanolone	5
Evaluation of alternative gas chromatographic and mass spectrometric behaviour of trimethylsilyl‐derivatives of non‐hydrolysed sulfated anabolic steroids	5
Comparison of three different blood matrices for the quantification of endogenous steroids using UHPLC‐MS/MS	5
Synthesis, characterization, method development, and validation of nor‐ethylmorphine hydrochloride reference material using established analytical techniques for dope control analysis	5
Analysis of potential phenylacetone precursors (ethyl 3‐oxo‐2‐phenylbutyrate, methyl 3‐oxo‐4‐phenylbutyrate, and ethyl 3‐oxo‐4‐phenylbutyrate) by gas chromatography/mass spectrometry and their convers	5
Effects of theophylline and theobromine on exercise performance and implications for competition sport: A systematic review	5
Frequency and type of adverse analytical findings in athletics: Differences among disciplines	5
Detection of the growth hormone secretagogue MK‐0677 in equine hair following oral administration	5
Evaluation of the detection of the homologous transfusion of a red blood cell concentrate in vivo for antidoping	5